In work to be described elsewhere, we have shown that the introduction of a deficiency in the DNA repair gene, XPC (XPC−/−) [33], into the BMC greatly enhances the potency of the PAH suppression (Rondelli, unpublished observation), which is now effective at 20 nM DMBA. The gene discussed is XPC; the disease is pulmonary arterial hypertension.